IL6 and cardiac hypertrophy: Our data provide evidence that cardiac fibroblast p38α is integral to ISO-induced cardiac hypertrophy and dysfunction and that this may be due to a paracrine signaling mechanism involving fibroblast secretion of the cardiomyocyte hypertrophy-inducing factor, IL-6.